📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Imaging DNA damage response by ?H2AX in vivo predicts treatment response to Lutetium-177 radioligand therapy and suggests senescence as a therapeutically desirable outcome. (2023)

First Author: O'Neill E

Attributed to: Imaging DNA damage repair during radionuclide therapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.7150/thno.82101

PubMed Identifier: 36923536

Publication URI: http://europepmc.org/abstract/MED/36923536

Type: Journal Article/Review

Volume: 13

Parent Publication: Theranostics

Issue: 4

ISSN: 1838-7640